1. Alzforum newsletter March 25, 2019: https://www.alzforum.org/news/research-news/biogeneisai-halt-phase-3-aducanumab-trials
2. Hsu D, Marshall GA. Primary and secondary prevention trials in Alzheimer disease: looking back, moving forward.
3. Maloney B, Lahiri DK. Epigenetics of dementia: understanding the disease as a transformation rather than a state.
4. Weinstein G, Preis SR, Beiser AS, Kaess B, Chen TC, Satizabal C. Clinical and environmental correlates of serum BDNF: A descriptive study with plausible implications for AD research.
5. Lauritzen I, Pardossi-Piquard R, Bourgeois A, Bécot A, Checler F. Does intraneuronal accumulation of carboxyl terminal fragments of the amyloid precursor protein trigger early neurotoxicity in Alzheimer’s disease?